Invention Grant
- Patent Title: Piperidine derivatives as HDAC1/2 inhibitors
-
Application No.: US17184118Application Date: 2021-02-24
-
Publication No.: US11702389B2Publication Date: 2023-07-18
- Inventor: John H. van Duzer , Ralph Mazitschek
- Applicant: Regenacy Pharmaceuticals, LLC
- Applicant Address: US MA Waltham
- Assignee: REGENACY PHARMACEUTICALS, LLC
- Current Assignee: REGENACY PHARMACEUTICALS, LLC
- Current Assignee Address: US MA Waltham
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque; Nicole Sassu
- The original application number of the division: US16433386 2019.06.06
- Main IPC: C07D211/58
- IPC: C07D211/58 ; C07D409/12 ; C07D409/14 ; C07D401/14 ; C07D401/12
Abstract:
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.
Public/Granted literature
- US20210179559A1 PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS Public/Granted day:2021-06-17
Information query
